Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2022-11-24 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
第三届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 20th meeting of the third board of directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to related announcements on the stock exchange platform. The content focuses on board meeting decisions and procedural details rather than financial results or reports. There is no indication of financial statements, audit information, or shareholder voting results at a general meeting. The document is clearly about board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is 2262 characters, which is consistent with a meeting resolution announcement rather than a full report or transcript.
2022-11-24 Chinese
独立董事关于第三届董事会第二十次会议相关事项的事前认可意见及独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' pre-approval and independent opinion on the company's anticipated 2023 related party transactions. It is a formal statement by independent directors regarding governance and compliance with laws and company bylaws, focusing on the fairness and legality of related party transactions. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of a report publication but a governance-related opinion document. Therefore, it fits best under Board/Management Information (MANG), which includes announcements related to board activities and management opinions.
2022-11-24 Chinese
关于2023年度开展远期结售汇等外汇衍生产品业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company's board regarding the approval and plan to conduct foreign exchange derivative product business for the year 2023. It details the business purpose, types of products, expected business scale, risk analysis, and risk control measures. The document is a formal announcement of a board resolution and business plan rather than a financial report or regulatory filing. It does not contain financial statements, audit information, or voting results. It is not a report publication announcement since it contains substantive content about the business plan and risk management. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about business activities that does not fit into more specific categories like capital updates or management changes.
2022-11-24 Chinese
关于召开2022年第三次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 third extraordinary general meeting of shareholders for Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes details about the meeting date, voting methods, agenda items to be discussed, registration procedures, and contact information. The document does not contain any financial statements, audit results, or detailed financial data. It is primarily an announcement informing shareholders about the meeting and how to participate, rather than the meeting materials or results themselves. The document length is 2613 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-11-24 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled '北京颖泰嘉和生物科技股份有限公司 投资者关系管理制度' which translates to 'Investor Relations Management System' of the company. It details the company's policies, principles, and procedures for managing investor relations, including communication methods, responsibilities, and compliance with laws and regulations. There are no financial statements, earnings data, or audit information present. The document is a governance-related policy document outlining internal rules and governance practices related to investor relations. Therefore, it fits best under the category of Governance Information (CGR). The document length is 6186 characters, indicating it is a full policy document rather than a brief announcement or notice.
2022-11-24 Chinese
西南证券股份有限公司关于北京颖泰嘉和生物科技股份有限公司预计2023年日常关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from Southwest Securities Co., Ltd. acting as the sponsor for Beijing Yingtai Jiahe Biotechnology Co., Ltd. It provides an opinion on the expected related party transactions for the year 2023. The content includes detailed descriptions of the types and amounts of related party transactions, the parties involved, pricing basis, approval and voting results from the board, and the sponsor's verification opinion. The document is 6675 characters long, which is substantial and contains detailed substantive information rather than just an announcement or certification. It is not a financial statement or earnings release but a specialized audit or verification report related to internal controls and compliance on related party transactions. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report on internal controls and compliance, not a full annual report or other category. Therefore, the correct classification is AR with high confidence. FY 2023
2022-11-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.